Mexico José Angel García Hinojosa, counsellor of the board of the Grupo Loeffler Russek, details how Loeffler’s impressive growth has forced the company to increase their manufacturing capacity. While Loeffler grew from a small Mexican business to one of the most prominent generics companies in the fast-growing Mexican market, Mr. García…
Switzerland Lukas Engelberger discusses the challenges and benefits of the healthcare system in Switzerland and the Canton of Basel-Stadt, new milestones in dentistry and the organizational structure between the hospitals and the canton, as well as the federal and cantonal jurisdiction. You are now two years into your four-year mandate as…
Ireland Tony O’Brien, Director General of the Irish Health Service Executive (HSE), highlights the reforms instituted in the past few years, key challenges faced, his thoughts on the sustainability of the Irish healthcare system, and his commitment to making it fit for the needs of its patients. The Health Service Executive…
Chiesi Mario Muniz, general manager of Chiesi Mexico, explains how the affiliate looks at becoming a comprehensive solution provider in the neonatal field, highlights the dramatic consequences of the health budget cuts recently released by the government, and shows how empowering its employees has led the affiliate to recently win a…
Pharma Sandra Sánchez, General Manager at PROBIOMED, explains the crucial role that biosimilars will play in the future healthcare system as well as the importance of complying with COFEPRIS’ regulations to expand PROBIOMED’s business within the region. Last time we met with you, you explained that PROBIOMED was following a three…
Healthcare The benefits of economic growth in the Philippines are slowly starting to trickle down to the poorest in society via a more inclusive and affordable healthcare system. Access to healthcare information is also improving, allowing Filipinos to better understand their health. “Better informed patients make better patients.” Noel Lantin, Medicomm Pacific You…
Ireland As a major innovative hub for (bio)pharma innovation, Ireland should be a place where innovative medicines are adopted quickly within the local healthcare system. IPHA director Oliver O’Connor explains the significance of the new 2016 IPHA agreement in contributing to a sustainable Irish healthcare budget and the delivery of innovative…
Health Pascal Strupler of the Federal Office of Public Health discusses the intricacies of the Swiss healthcare system, highlighting the importance of the NCD in health prevention, strategies for cost reduction, and his support for open dialogue between healthcare stakeholders in order to provide the public with an accessible and efficient…
Health Raúl Riquelme Cacho, president of the health commission of the Confederation of Industrial Chambers of the United Mexican States (CONCAMIN), reveals the recent alignment of CONCAMIN, which stands as the most important industry organization of Mexico, with the main pharmaceutical associations, and discusses the cross-sector objectives that unite these stakeholders:…
Pharma Lundbeck Mexico GM Oscar Parra discusses raising awareness of depression in Mexico, Lundbeck’s innovative treatments for depression and Alzheimer’s, and managing to navigate the country’s regulatory process to ultimately benefit the patient. Lifestyle related illnesses are a major problem in Mexico, with 13 million people suffering from diabetes and 71…
Biotech The chairman of BioSingapore, Dr. Siew Hwa Ong, discusses the opportunities and challenges facing biotech SMEs in Singapore, government efforts to enhance the business environment for these SMEs, and facilitating more collaboration between companies as the most prominent pathway for future development. Could you please introduce yourself to our international…
Pharma Teodoro Padilla, Executive Director at the Pharmaceutical and Healthcare Association of the Philippines, and Reiner Gloor, Advisor and Honorary Member, discuss the current objectives and goals of the association, how they are adapting to recent changes in the country’s healthcare landscape, and the impact of the rise of generics. To begin, could…
See our Cookie Privacy Policy Here
